| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.4 |
6e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |